Strides Pharma Science Limited — Others, 08-08-2025: Shareholders meeting

Strides Pharma Science announced that its 34th Annual General Meeting successfully concluded, with shareholders approving all proposed resolutions by an overwhelming majority. Key decisions include the adoption of the audited financial statements for the last fiscal year, the declaration of a final dividend, and the re-appointment of Mr. Aditya Arun Kumar as a director. Shareholders also approved the appointment of the Secretarial Auditor and Cost Auditors for the upcoming fiscal year. This solid backing by shareholders signals stable governance and continued operational focus for the company.